Literature DB >> 29209851

Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Roberto de la Plaza Llamas1, José Manuel Ramia Ángel2, Vladimir Arteaga Peralta2, Cristina García Amador2, Aylhín Joana López Marcano2, Aníbal Armando Medina Velasco2, Begoña González Sierra2, Alba Manuel Vázquez2, Raquel Aránzazu Latorre Fragua2.   

Abstract

INTRODUCTION: Surgery for primary hyperparathyroidism (PHPT) is traditionally deemed to be successful if serum calcium levels return to normal 6 months after parathyroidectomy. Regular monitoring of serum calcium and parathyroid hormone (PTH) in the follow-up of patients after parathyroidectomy for PHPT has drawn attention to the presence of a normocalcemic group of patients with elevated PTH (NCePTH) during the post-operative period. The etiological factors and mechanisms underlying this condition, its consequences, and the possibility of treatment are the object of this study.
MATERIALS AND METHODS: We conducted an unlimited PubMed search updated on March 31, 2017, which yielded 1628 results. We selected 37 articles, 33 of which included cases of NCePTH in their series and 23 performed statistical studies to assess factors associated with NCePTH.
RESULTS: The maximum mean prevalence of NCePTH in the various series was 23.5%, ranging from 3 to 46%. Many factors were associated with NCePTH. The most important were higher pre-operative PTH, low pre-operative 25 (OH) D3, lower pre-operative creatinine clearance and greater adenoma weight. The origin of NCePTH may be multifactorial, since several factors were implicated in the etiology. NCePTH does not seem to be related to an increase in PHPT recurrence, although this possibility should not be dismissed. Vitamin D deficiency should be corrected. Treatment with calcium supplements seems to be clearly beneficial.
CONCLUSION: The prevalence of NCePTH is high. The causes of secondary hyperparathyroidism should be investigated carefully. Patients require treatment and long-term follow-up.

Entities:  

Keywords:  Hyperparathyroidism, Primary; Parathyroid hormone; Parathyroidectomy; Post-operative hyperparathyroidism; Post-operative period; Review

Mesh:

Substances:

Year:  2017        PMID: 29209851     DOI: 10.1007/s00405-017-4836-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years.

Authors:  Melanie Goldfarb; Stephen Gondek; George L Irvin; John I Lew
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

2.  Elevated parathyroid hormone after parathyroidectomy delays symptom improvement.

Authors:  Priya R Pathak; Sara E Holden; Sarah C Schaefer; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2014-03-02       Impact factor: 2.192

3.  Normocalcemic hyperparathyroidism: preoperatively a disease, postoperatively cured?

Authors:  Heather C Stuart; Adrian Harvey; Janice L Pasieka
Journal:  Am J Surg       Date:  2014-03-12       Impact factor: 2.565

Review 4.  Significance of elevated parathyroid hormone after parathyroidectomy for primary hyperparathyroidism.

Authors:  Sarah C Oltmann; Naim M Maalouf; Shelby Holt
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

5.  Pattern of calcium and parathyroid hormone normalization at 12-months follow-up after parathyroid operation.

Authors:  Olga A Lavryk; Allan E Siperstein
Journal:  Surgery       Date:  2016-11-29       Impact factor: 3.982

6.  Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Isaksson; Pia Lindblom; Anders Bergenfelz
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

7.  Parathyroid hormone: before and after parathyroidectomy.

Authors:  Q Y Duh; C D Arnaud; K E Levin; O H Clark
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

8.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

9.  Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency.

Authors:  I G Lewin; S E Papapoulos; G N Hendy; S Tomlinson; J L O'Riordan
Journal:  Clin Sci (Lond)       Date:  1982-04       Impact factor: 6.124

10.  What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?

Authors:  Li Ning; Rebecca Sippel; Sarah Schaefer; Herbert Chen
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

View more
  5 in total

1.  Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Authors:  Marie Caldwell; Jeff Laux; Marshall Clark; Lawrence Kim; Janet Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

2.  High parathyroid hormone levels after parathyroidectomy for parathyroid adenoma are not related to the cellularity of the remaining glands.

Authors:  Rotem Sagiv; Bertha Delgado; Re'em Sadeh; Sagi Shashar; Merav Fraenkel; Ksenia M Yegodayev; Moshe Elkabets; Ben-Zion Joshua
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-08

3.  PARATHYROID ADENOMA MIMICKING TUBERCULOSIS IN A PERITONEAL DIALYSIS PATIENT.

Authors:  S Karahisar Şirali; Ö Kavraz Tomar; R Büberci; A Z Bal; M Duranay
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

4.  Ectopic Parathyroid Adenoma in an 11-Year-Old Girl: Case Report and Literature Review.

Authors:  Myrto Eleni Flokas; Gulnigor Ganieva; Amanda Grieco; Levon Agdere
Journal:  AACE Clin Case Rep       Date:  2020-11-28

5.  Analysis of the cause and management of persistent laboratory abnormalities occurring after the surgical treatment of primary hyperparathyroidism.

Authors:  Ji-Eun Lee; Namki Hong; Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Yumie Rhee
Journal:  Ann Surg Treat Res       Date:  2022-07-07       Impact factor: 1.766

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.